OpenURL Connection Search

Select item for more details and to access through your institution.

Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D).
Published in:
2022
By:
- Pondé, Noam;
- Agbor‑Tarh, Dominique;
- Dal Lago, Lissandra;
- Korde, Larissa A.;
- Hilbers, Florentine;
- Jackisch, Christian;
- Werner, Olena;
- Gelber, Richard D.;
- Jatoi, Aminah;
- Dueck, Amylou C.;
- Moreno‑Aspitia, Alvaro;
- Sotiriou, Christos;
- de Azambuja, Evandro;
- Piccart, Martine
Publication type:
Correction Notice
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
Published in:
Breast Cancer Research & Treatment, 2021, v. 185, n. 1, p. 107, doi. 10.1007/s10549-020-05915-9
By:
- Pondé, Noam;
- Agbor-Tarh, Dominique;
- Dal Lago, Lissandra;
- Korde, Larissa A.;
- Hilbers, Florentine;
- Jackisch, Christian;
- Werner, Olena;
- Gelber, Richard D.;
- Jatoi, Aminah;
- Dueck, Amylou C.;
- Moreno-Aspitia, Alvaro;
- Sotiriou, Christos;
- de Azambuja, Evandro;
- Piccart, Martine
Publication type:
Article
Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial.
Published in:
2020
By:
- Di Cosimo, Serena;
- Porcu, Luca;
- Agbor-tarh, Dominique;
- Cinieri, Saverio;
- Franzoi, Maria Alice;
- De Santis, Maria Carmen;
- Saura, Cristina;
- Huober, Jens;
- Fumagalli, Debora;
- Izquierdo, Miguel;
- Piccart, Martine;
- Daidone, Maria Grazia;
- de Azambuja, Evandro
Publication type:
journal article
Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies.
Published in:
Journal of Clinical Immunology, 2018, v. 38, n. 8, p. 886, doi. 10.1007/s10875-018-0562-3
By:
- Mallick, Rajiv;
- Jolles, Stephen;
- Kanegane, Hirokazu;
- Agbor-Tarh, Dominique;
- Rojavin, Mikhail
Publication type:
Article
STAT3 activation in HER2‐positive breast cancers: Analysis of data from a large prospective trial.
Published in:
International Journal of Cancer, 2021, v. 148, n. 6, p. 1529, doi. 10.1002/ijc.33385
By:
- Sonnenblick, Amir;
- Agbor‐tarh, Dominique;
- Azambuja, Evandro;
- Hultsch, Susanne;
- Izquierdo, Miguel;
- Liu, Minetta;
- Pruneri, Giancarlo;
- Harbeck, Nadia;
- Piccart, Martine;
- Moreno‐Aspita, Alvaro;
- Granit, Roy Zvi;
- Rouas, Ghizlane;
- Fahoum, Ibrahim;
- Sotiriou, Christos
Publication type:
Article
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.
Published in:
2020
By:
- Eiger, Daniel;
- Pondé, Noam F.;
- Agbor-Tarh, Dominique;
- Moreno-Aspitia, Alvaro;
- Piccart, Martine;
- Hilbers, Florentine S.;
- Werner, Olena;
- Chumsri, Saranya;
- Dueck, Amylou;
- Kroep, Judith R.;
- Gomez, Henry;
- Láng, István;
- Rodeheffer, Richard J.;
- Ewer, Michael S.;
- Suter, Thomas;
- de Azambuja, Evandro
Publication type:
journal article
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.
Published in:
2016
By:
- Sonnenblick, Amir;
- de Azambuja, Evandro;
- Agbor-tarh, Dominique;
- Bradbury, Ian;
- Campbell, Christine;
- Yingjie Huang;
- Dueck, Amylou C.;
- Pritchard, Kathleen I.;
- Wolff, Antonio C.;
- Jackisch, Christian;
- Lang, Istvan;
- Untch, Michael;
- Smith, Ian;
- Boyle, Frances;
- Binghe Xu;
- Gomez, Henry;
- Perez, Edith A.;
- Piccart, Martine;
- Azim Jr., Hatem A.;
- Huang, Yingjie
Publication type:
journal article

Found: 7

Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D).

Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).

Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial.

Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies.

STAT3 activation in HER2‐positive breast cancers: Analysis of data from a large prospective trial.

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.